Alnylam Pharmaceuticals continues to lead in RNAi therapeutics with a standout quarter!

Aug 11

Written By Kimberly Hicks

Kimberly Hicks

argenx Delivers Strong First Half Performance!

Apellis Pharmaceuticals receives FDA approval of EMPAVELI® (pegcetacoplan)